10-Nov-2025 3:13 PM CST - Business Wire Assertio Reports Third Quarter 2025 Financial Results Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients needs, today reported financial results for the third quarter ended September 30, 2025. Mark Reisenauer, Chief Executive Officer, stated: In the third quarter we achieved financial results that position us to achieve our full-year 2025 guidance. We also advance
10-Nov-2025 3:13 PM CST - Business Wire Assertio Reports Third Quarter 2025 Financial Results Assertio Holdings, Inc. (Assertio or the Company) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients needs, today reported financial results for the third quarter ended September 30, 2025. Mark Reisenauer, Chief Executive Officer, stated: In the third quarter we achieved financial results that position us to achieve our full-year 2025 guidance. We also advance
